Dafinchi AI

Industrial

Kimball Electronics is opening a new 300,000 square foot medical facility in Indianapolis, scheduled for grand opening in November 2025.
The new facility is designed to support expansion into cold chain management, device assembly, and precision molded plastics, beyond traditional printed electronics.
Management expects the Indianapolis plant to handle hundreds of millions of dollars in revenue, with potential capacity exceeding $0.5 billion.
This expansion aims to diversify revenue streams and leverage the company's expertise in complex, regulated medical manufacturing environments.
The company is positioning itself to take on more complex programs and increase margins in the medical CMO segment.
Strategic focus on high-reliability, high-complexity programs aligns with the new facility's capabilities and growth plans.

Industrial

Adjusted net income was $8.4 million or $0.34 per diluted share, compared to $9.7 million or $0.38 last year.
Adjusted operating income was $19.6 million or 5.2% of sales, slightly below prior year’s 5.3%.
Automotive sales declined 13% year-over-year to $184 million, impacted by loss of electronic braking program in Reynosa.
Cash generated from operations was $78.1 million in Q4, marking the sixth consecutive quarter of positive cash flow.
Gross margin in Q4 was 8%, down 50 basis points from prior year but showing sequential improvement.
Industrial sales decreased 12% year-over-year excluding AT&M, with some stability in climate control systems.
Medical segment sales grew 5% year-over-year to $107 million, representing 28% of total revenue.
Q4 net sales were $381 million, down 8% year-over-year excluding divested AT&M business.

Industrial

1mo

The company's pipeline of identified projects exceeds $7.6 billion, indicating strong future growth potential.
Backlog at the end of Q2 increased by 49% year-over-year to $418.1 million, reflecting robust demand.
Management attributes the backlog growth to higher baseload generation demand and strategic project wins.
The project pipeline includes potential plant conversions, upgrades, and behind-the-meter data center projects.
The backlog and pipeline reinforce the company's optimistic outlook for 2025 and beyond.

ORGN

Industrial

Adjusted EBITDA breakeven expected to shift from 2026 to 2027 due to production delays.
Ended Q2 2025 with $69 million in cash, cash equivalents, and marketable securities.
Held $9 million in land for sale in Geismar, Louisiana, expected to generate additional cash.
Manufacturing output expected to be reduced by approximately 50% in 2026 and 15% in 2027 compared to prior estimates.
Net accounts receivable balance of $17.9 million related to legacy supply chain activation program being wound down in 2025.
Revised 2026 revenue guidance down to $20 million to $30 million from prior $50 million to $70 million due to manufacturing delays.
Revised 2027 revenue guidance to $100 million to $200 million, down from prior $150 million to $210 million.

BRC

Industrial

Brady achieved a new quarterly record high adjusted EPS of $1.26, up 5.9% year-over-year, driven by strategic cost reductions and increased R&D investment.
The company grew organic sales by 2.4% in Q4, with acquisitions contributing an additional 11.3%, highlighting a balanced growth approach.
Management emphasized that significant cost outlays, including restructuring and facility closures, contributed to margin expansion despite challenging macro conditions.
R&D spending increased by 31% in Q4, reaching nearly $80 million for the year, underpinning a focus on high-margin engineered products.

Earnings Feed